Merit Medical Systems (MMSI) EBIT (2010 - 2026)

Merit Medical Systems has disclosed EBIT across 17 years of filings, most recently posting $44.2 million for Q1 2026.

• EBIT for Q1 2026 came in at $44.2 million, up 7.61% year-over-year; the trailing twelve-month figure through Mar 2026 was $39.0 million (up 6.59% YoY), and the FY2025 annual result was $35.9 million, up 13.96% from the prior year.
• EBIT came in at $44.2 million for Q1 2026 at Merit Medical Systems, up from -$94.6 million in the prior quarter.
• In the past five years, EBIT ranged from a high of $46.9 million in Q2 2025 to a low of -$94.6 million in Q4 2025.
• The 5-year median for EBIT is $30.4 million (2022), against an average of $13.1 million.
• Across the five-year window, EBIT jumped 161.45% in 2022 and tumbled 319.59% in 2023, its largest moves.
• Merit Medical Systems' EBIT stood at $30.4 million in 2022, then plunged by 319.59% to -$66.8 million in 2023, then tumbled by 31.2% to -$87.6 million in 2024, then fell by 7.99% to -$94.6 million in 2025, then surged by 146.66% to $44.2 million in 2026.
• The last three EBIT figures came in at $44.2 million (Q1 2026), -$94.6 million (Q4 2025), and $42.6 million (Q3 2025), per Business Quant data.